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ABSTRACT  23 
Problem: Surfactant Protein D (SP-D), a pattern recognition protein that regulates inflammation 24 
and immune homeostasis, is expressed by testicular germ cells under the influence of 25 
testosterone. The present study investigates the role of SP-D in testicular immune-privilege and 26 
sperm functions.  27 
Method of study: Testicular levels of cytokines and immunoregulatory molecules were 28 
evaluated in lipopolysaccharide (LPS) challenged SP-D gene knock-out mice (SP-D
-/-
). Further, 29 
sperm functions were assessed by CASA and in vitro capacitation.  The effect of a recombinant 30 
fragment of human SP-D (rhSP-D) on LPS induced testicular inflammation and sperm motility 31 
was assessed in wild type (WT) mice. 32 
Result: Endogenous absence of SP-D led to significantly increased testicular levels of 33 
immunosuppressive molecules viz., Serpina3, IL-12p40, TGF-β1 and IL-10, and reduced levels 34 
of immune cell activation markers, CD86, IL-2 and ITGAX. These compensatory mechanisms 35 
resulted in markedly blunted levels of TNF-α, IL-12p40, MIP-1α, G-CSF and IL-6 in response to 36 
LPS challenge. Notably, exogenous supplementation of rhSP-D salvaged the WT mice from 37 
LPS-induced pro-inflammatory immune response and impairment of sperm motility by up-38 
regulating the levels of TGF-β1 and IL-10. 39 
Conclusion: The study highlights the  involvement of SP-D in maintenance of testicular immune 40 
privilege and its indirect contribution to male fertility.  41 
 42 






It is estimated that nearly 15 % cases of male factor infertility are attributed to 47 
inflammatory or autoimmune conditions
1
. An exaggerated inflammatory response to male 48 
urogenital tract infections can have detrimental effect on testicular spermatogenesis and sperm 49 
motility leading to a loss of fertility
2
. The mammalian testis is an immune privileged site where 50 
adaptive immune responses are finely regulated in order to protect auto-immunogenic sperm 51 
antigens
3
. The testicular cells have been shown to express a number of pattern recognition 52 
receptors (PRRs) such as Toll-Like Receptors, RIG-I-Like receptors and NOD-like receptors, 53 
which are actively involved in the testicular innate immune response to infections 
4, 5, 6
. The 54 
innate and adaptive immune responses in the testis should be finely balanced to protect the auto-55 
antigenic spermatozoa and to provide protection against infections. Thus, understanding the 56 
regulation of innate and adaptive immunity within the male reproductive tract is important for 57 
designing strategies to improve infertility.  58 
Surfactant Protein D (SP-D), a pattern recognition protein of the collectin family, is an 59 
integral component of the innate immune system
7
. We have recently reported the presence of SP-60 
D in the murine testis and on the caudal sperm
8
. Several reports have previously demonstrated 61 
the presence of SP-D in male reproductive tract of human, rodent and stallion
9, 10, 11
. The 62 
protective role of SP-D in pulmonary infections and inflammation has been studied 63 
comprehensively
12
. Through its C-terminal lectin domain, SP-D binds to carbohydrate moieties 64 
on the surface of pathogens and mediates phagocytosis and clearance of pathogens through the 65 
interaction of its collagen region with phagocytic cells
7
. SP-D is also known to play an important 66 
role in the control of inflammation, clearance of apoptotic and necrotic cells, and modulation of 67 
the activity of immune cells [macrophages, dendritic cells (DCs) and T-lymphocytes] via its 68 
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direct interaction with cell surface receptors such as CD14, SIRP-α, and CD91-calreticulin13, 14, 69 
15




 Th cell 70 
proliferation and IL-2 production
15, 16
.  71 
The role of SP-D as a host defence molecule in the rodent prostate has been 72 
demonstrated
11
. Recently, we have shown the testicular germ cells as a source of SP-D and 73 
testosterone as a positive regulator of SP-D expression in the testis of mice
8
. Importantly, we 74 
have reported an up-regulation of SP-D in murine testis following lipopolysaccharide (LPS) 75 
challenge
8
. LPS, a structural component of the outer membrane of Gram-negative bacteria, is the 76 
primary pathological factor associated with chronic inflammatory diseases and male reproductive 77 
impairments
17
. SP-D is known to inhibit LPS mediated inflammation through direct binding to 78 
LPS receptor CD14
18
. The interaction of SP-D with the extra-cellular domains of TLR-2 and 79 
TLR-4 via its C-terminal domain has been reported
19
. SP-D has also been shown to inhibit the 80 
LPS- induced inflammatory response in alveolar macrophages and TLR4/MD-2-transfected 81 
HEK293 cells
20
. Therefore, examining the immunological role of SP-D in the testis and on sperm 82 
functions under inflammatory conditions is likely to shed light on its role in male fertility. 83 
 SP-D gene knock-out (SP-D
-/-
) mice have been previously used to dissect the in vivo 84 
functions of SP-D in the lung, brain and female reproductive tract
21, 22, 23
. Despite being a 85 
systemic knock-down model, the genetic deficiency of SP-D was associated with tissue specific 86 
immuno-phenotypes at these sites. SP-D deficiency resulted in an exaggerated pulmonary 87 
inflammation with increased infiltration of inflammatory cells and pro-inflammatory cytokine 88 
levels following pathogen or allergen challenge
21
. We have recently shown that,  the SP-D
-/-
 89 
female mice exhibit an extended estrous cyle with an altered serum profile of ovarian hormones, 90 
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significantly smaller litter size due to pre-implantation embryo loss and a blunted pro-91 
inflammatory response to LPS administration in pregnant mice
23
.    92 
In view of the role of SP-D in the control of inflammation and its relevance in male 93 
fertility, we examined the functional importance of SP-D in testicular immune privilege and 94 
sperm functions. We show that SP-D
-/- 
male mice have significantly reduced weight of the testis 95 
and epididymis. In addition, a reduced degree of protein tyrosine phosphorylation was observed 96 
in the capacitated sperm from SP-D
-/- 
mice. Although mating studies did not reveal any 97 
significant defect in fecundity, we observed an altered immune milieu in the testis of SP-D
-/- 98 
mice that resulted in a subdued testicular inflammatory response following LPS challenge. 99 
Importantly, our data reveals a protective role of exogenous rhSP-D on testicular inflammation 100 
and sperm motility in LPS challenged wild type (WT) mice. Taken together, our results highlight 101 
the importance and plausible contribution of SP-D in the testicular immune regulation and male 102 












Materials and Methods 113 
Animals 114 
This study was reviewed and approved by the Institutional Animal Ethics Committee 115 
(IAEC No. 04/15). Mice with the targeted deletion of SP-D (SP-D
-/-
) on a Swiss black 116 
background (outbred mice) and wild type mice (WT) of the similar genetic background were 117 
obtained from the laboratory of Dr. Jefferey Whitsett, Cincinnati Children Hospital Medical 118 
Centre, USA. The study was conducted in accordance with the Institutional Guidelines for the 119 
care and use of experimental animals. Animals were maintained under controlled conditions of 120 




 mice 123 
The SP-D
-/-
 mice have been generated using neomycin replacement strategy with the 124 
deletion of second exon and a part of intron 2 of SP-D gene by a homologous recombination
24
. 125 
These animals were genotyped as reported previously
23
. Briefly, DNA was extracted from tail 126 
clips using RED Extract-N-Amp Tissue PCR Kit (Sigma, St. Louis, MO, USA) as per the 127 
manufacturer’s protocol. The genotyping was carried out by PCR analysis using primers specific 128 
for exon 2 of the SP-D
 
gene and neomycin resistance (Neo) gene. The primers were designed 129 
using NCBI Primer Blast software (Table 1). The PCR products were run on a 2 % agarose gel 130 
(GeNei
TM
, Bangalore, India) to confirm the presence or absence of the SP-D gene. 131 
 132 
Histological analysis of testis  133 
 For histological evaluation, testes from 8 week old SP-D
-/-
 and WT mice (n = 5 each) 134 
were fixed in 4 % (w/v) buffered formalin (Qualigens, Mumbai, India), embedded in paraffin, 135 
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and sectioned at a thickness of 5 μm. The testicular cross-sections were stained with hematoxylin 136 
and eosin (Qualigens), dehydrated and mounted using DPX mountant (Fisher Scientific, 137 
Mumbai, India). Images were captured using Leica AS LMD microsystem. 138 
 139 
Hormone measurements 140 
Serum and intra-testicular levels of testosterone and estradiol in 8 week old SP-D
-/-
 and 141 
WT mice (n = 5 each) were measured using hormone specific ELISA kits according to the 142 
manufacturer’s protocol (Diagnostic Biochem Canada Inc).  143 
 144 
Fertility studies 145 
The reproductive capacity of SP-D
-/- 
male mice was evaluated by cohabitation with WT 146 
female mice. Briefly, sexually mature (2-4 month old) littermate males of SP-D
-/- 
and WT 147 
genotype were caged individually with 2 mature WT females for 2 months (n = 5 each). The 148 
fertility was assessed by evaluating the percentage of females achieving pregnancy, number of 149 
offspring per litter, litter weight, and period between the beginning of mating and delivery of the 150 
pups. 151 
 152 
Assessment of Sperm motility and in vitro capacitation 153 
Caudae epididymis from 8- 10 week old SP-D
-/-
 and WT mice (n = 5 each) were excised 154 
and rinsed with M199 media (HiMedia, Mumbai, India). Sperm were allowed to exude for 10 155 
min at 37°C in 5 % CO2 through three to five incisions in 500 μl of fresh M199 media. The 156 
sperm preparation was immediately subjected to motility analysis, using CASA (Computer 157 
Assisted Sperm Analyzer, Hamilton-Thorne Research, Beverly, Mass). For each sample, a 20 μl 158 
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of sperm suspension, in at least 5 different microscopic fields was scored at 37°C. The pipette 159 
tips, slides and coverslips, used for motility analysis, were maintained at 37°C throughout the 160 
analysis. The validated default Mouse 2 analysis settings, provided by Hamilton Thorne, were 161 
used in the present study. These default settings were: 60 frames per second; number of frames, 162 
30; minimum contrast, 30; minimum cell size, 4 pixels; cell size, 13 pixels; cell intensity, 75; 163 
cells counted as progressive if average path velocity (VAP) > 50 μm/sec and straightness (STR) 164 
> 50%; cells counted as slow if VAP cutoff, 10 μm/sec and straight-line velocity (VSL) cutoff, 0 165 
μm/sec; minimum static intensity gate, 0.10; maximum intensity gate, 1.52; minimum static size 166 
gate, 0.13 pixels; maximum static size gate, 2.43 pixels; minimum static elongation gate, 5 pixels 167 
and maximum static elongation gate, 100 pixels. 168 
We also compared the sperm motility parameters between SP-D
-/-
 and WT mice after an 169 
inflammatory episode by an i.p. injection of pyrogen free-saline with or without 5 mg/ kg body 170 
weight of LPS (from E. coli, 0111:B4, Sigma). Mice were sacrificed 24 h post-LPS challenge (n 171 
= 5 per group) by cervical dislocation and caudae epididymis were excised. The sperm 172 
suspension was prepared for motility analysis by CASA, as described above. 173 
For in vitro capacitation, the caudae epididymis from SP-D
-/-
 and WT mice were excised 174 
and rinsed with DMEM F-12 media (Sigma). The sperm were allowed to exude for 10 min at 175 
37°C in 5 % CO2 via three to five incisions in 500 μl of fresh DMEM F-12 media. The resulting 176 
sperm suspension was washed twice in DMEM F-12 media at 500 g for 5 min. For capacitation, 177 
the sperm pellet was suspended in DMEM F-12 media supplemented with 5 mg/ ml Bovine 178 
Serum Albumin (Sigma) and 15 mM NaHCO3 (Sigma), adjusted to the final concentration of 1 x 179 
10
7
 sperm cells/ ml, and incubation was allowed to proceed for different time points viz., 0 min, 180 
15 min, 60 min and 90 min at 37°C in 5 % CO2. Following incubation, the sperm motility was 181 
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analysed by CASA and the degree of protein tyrosine phosphorylation was assessed by western 182 
blotting. 183 
 184 
Sperm count 185 
Cauda epididymis from adult SP-D
-/-
 and WT mice were placed in a small clean petri dish 186 
containing 1 ml PBS (n = 5 per genotype). Up to three to five small incisions were made in the 187 
cauda to release the sperm, and the suspension was then allowed to settle at 37°C for 30 min. 188 
Sperm suspension was loaded on both sides of the Neubuaer’s Chamber (Hemocytometer) and 189 
the number of sperm was counted at 40 X magnification. Sperm count was performed in 190 
triplicate for each sample. Replicate counts on two separate dilutions of each sample were 191 
performed to account for plausible uneven distribution of spermatozoa despite thorough mixing. 192 
 193 
Collection of spermatozoa for western blotting  194 
Spermatozoa incubated under capacitating condition at different time points were 195 
collected by centrifugation at 5000 g for 5 min at 4°C. The resulting sperm pellet was suspended 196 
in lysis buffer containing 50 mM Tris HCl (Sigma), pH 7.6, 150 mM NaCl (Thermo Fisher), 1 % 197 
(v/v) Triton X-100 (Sigma), 0.5 % (w/v) SDS (Sigma) and 1 % (v/v) protease inhibitor (GE 198 
Healthcare, Little Chalfont, United Kingdom) and vortexed for 10 min. The lysate was 199 
centrifuged at 10,000 g for 15 min at 4°C and the resulting supernatant was boiled with SDS-200 
PAGE sample buffer for 5 min. 40 μg of sperm protein was used to detect tyrosine 201 





Assessment of testicular immune milieu of SP-D
-/-
 and WT mice  205 
To evaluate the immune milieu, testis from 8 week old SP-D
-/-
 and WT mice (n = 5 each), 206 
was collected for RNA and protein extraction to estimate the levels of immunoregulatory 207 
molecules [such as, CD274, indole-amine 2,3- dioxygenase (IDO), matrix metalloproteinase 2 208 
(MMP-2), matrix metalloproteinase 9 (MMP-9), matrix metalloproteinase 12 (MMP-12), FasL, 209 
Surfactant Protein A (SP-A), Mannan Binding Lectin A (MBL-A) and serine proteinase inhibitor 210 
family A member 3 (serpina3)], and cytokines [such as, Activin-A, Activin-B, Inhibin-A, 211 
Inhibin-B, IL-1α, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-13, IL-17, keratinocyte chemoattractant 212 
(KC), monocyte chemoattractant protein -1 (MCP-1), macrophage migration inhibitory factor 213 
(MIF), macrophage inflammatory protein – 1β (MIP-1β), TGF-β1 and TNF-α] by real time RT-214 
PCR, western blotting and multiplex cytokine assay (Bio-rad, USA). Flow cytometric analysis 215 




T- lymphocytes, 216 
F4/80
+
 macrophages and CD11c
+
 dendritic cells) in the interstitial spaces of the testis of SP-D
-/-
 217 
and WT mice (n = 10 each). The activation status of these immune cells was assessed by 218 
measuring the testicular levels of their activation markers (viz., CD40L, MHC class II, CD86 and 219 
IL-2) by real time RT-PCR and western blotting (n = 5 each). The primers for all immune 220 
molecules were designed using NCBI Primer Blast software and are listed in Table 1. 221 
 222 
LPS induced inflammatory response in the testis of SP-D
-/-
 and WT mice 223 
 To evaluate the degree of LPS mediated inflammatory response in the testis of 8- 10 224 
week old SP-D
-/-
 and WT mice, systemic inflammation was induced by an i.p. injection of 100 μl 225 
of pyrogen free-saline containing 0.1 mg/ kg body weight (low dose) or 5 mg/ kg body weight 226 
(high dose) of LPS (from E. coli, 0111:B4; Sigma). A separate group of mice (control) were 227 
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injected with equal volumes of saline (n = 5 per treatment group). Mice were sacrificed 6 and 24 228 
h after LPS challenge by cervical dislocation and testis tissues were snap-frozen for analysing the 229 
expression of steroid hormones by hormone specific ELISA kits  (DBC) and that of cytokines by 230 
multiplex cytokine assay (Biorad).  231 
 232 
Administration of exogenous recombinant human SP-D (rhSP-D)  233 
The expression and purification of a fragment of human SP-D (rhSP-D), containing 8 N-234 
terminal Gly-Xaa-Yaa triplets followed by the α-helical coiled-coil neck region and a globular C- 235 
type lectin domain was carried out as described previously
25
. 8 week old WT mice were injected 236 
i.p. with 5 mg/ kg body weight of LPS in 100 μl of pyrogen free-saline followed by an i.p. 237 
administration of 2.5 mg/ kg body weight of rhSP-D or saline alone (n = 5 per treatment group). 238 
Animals were sacrificed 24 h post rhSP-D injection and testes tissues were processed for RNA 239 
extraction and histopathology, while the epididymis was processed for histopathology and sperm 240 
motility analysis.  241 
 242 
Multiplex Cytokine analysis 243 
 Testis tissues collected from SP-D
-/- 
and WT mice were rinsed in PBS and homogenized. 244 
Tissue lysates were prepared using Bio-Plex cell lysis kit (Bio-Rad) and protein concentration in 245 
the resulting supernatants was estimated using the Micro BCA protein assay kit (Thermo Fisher 246 
Scientific). Samples were pooled (5 mice/ genotype) and the levels of pro-inflammatory 247 
cytokines in the supernatants were analysed using the Bio-Plex Pro Mouse Cytokine 23-plex 248 
Assay (Bio-Rad) as per the manufacturer’s protocol. The assay was performed twice to validate 249 
the results and values were plotted as mean (of 6 values) ± SD. 250 
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RNA isolation and real time RT – PCR analysis 251 




was extracted using TRIsoln 252 
reagent (GeNei
TM
) and treated with DNase I (Thermo Scientific, Rockford, USA) at 37°C for 30 253 
min to eliminate any potential genomic DNA contamination. The yield and quality of resulting 254 
RNA was evaluated by determining the A260: A280 ratio. 2-3 g of RNA was reverse 255 
transcribed using Superscript
TM
 III first strand synthesis kit (Invitrogen, Carlsbad, CA, USA). 1 256 
l of cDNA was used for subsequent real time PCR reactions. For all experiments, murine 18s 257 
was used as an internal quality control. Primers for amplification of cDNAs were designed using 258 
NCBI Primer BLAST Software (Table 1). Real time PCR of diluted cDNA was carried out on 259 
Bio-Rad CFX 96
TM
 Thermal Cycler machine (Bio-Rad). The specificity of each PCR reaction 260 
was validated by a melt curve analysis followed by visualization of the amplification products on 261 
2 % (w/v) agarose gel (GeNei
TM
) for desired product size.  262 
 263 
Western blotting 264 
Testis tissues were homogenised in 400 μl of ice-cold cell lysis buffer containing 265 
protease inhibitor (GE Healthcare) and nuclease mix (GE Healthcare). After 1 h incubation on 266 
ice, the homogenates were centrifuged at 15000 g for 20 min at 4°C. The protein concentration in 267 
the resulting supernatant was estimated by Micro BCA
TM
 protein assay kit (Thermo Fisher 268 
Scientific). The aliquots of the supernatant were diluted in Laemmli sample buffer and boiled for 269 
10 min. Equal amount of proteins (40 μg) from testis and sperm lysate were separated on 10 % 270 
SDS-PAGE polyacrylamide gel (Biorad). After electrophoresis, the separated proteins were 271 
transferred onto PVDF membranes (Pall Corporation, New York, USA), blocked for 45 min 272 
using 3 % (w/v) skimmed milk protein in TBS (Tris Buffered Saline) and probed overnight at 273 
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4°C with rabbit polyclonal anti-mouse primary antibodies against serpina3 antibody (1:800, 47 274 
kDa, orb215432, Bioryt Ltd., Cambridge, UK), CD86 (1: 1000, 38 kDa, A1199, Abclonal, 275 
Baltimore Avenue, College Park, MD), TGF-β1 (1: 1000, 44 kDa A2124, Abclonal), IL-2 (1: 276 
1000, 18 kDa, A8029, Abclonal), and pJAK-2 (Tyr 1007/Tyr 1008) (1: 500, 128 kDa, sc-16566, 277 
Santa Cruz Biotechnology, Inc., CA, USA). Next, the blots were washed in TBS containing 0.1 278 
% (v/v) Tween 20 (GeNei 
TM
) and probed for 1 h with goat polyclonal anti-rabbit IgG-279 
horseradish peroxidase (HRP) (1:6000, AS014, Abclonal). ECL prime western blotting reagent 280 
(Thermo Scientific Pierce) was used for developing the blots on X-ray films. Equal loading and 281 
extract degradation were checked by Ponceau S (GeNei 
TM
) staining and via anti- β-actin (1: 282 
2500, 42 kDa, ab8227, Abcam, Cambridge, MA, USA) and anti- α- tubulin monoclonal 283 
antibodies (1: 10000, 50 kDa, T6074, Sigma). 284 
 285 
Flow cytometry 286 
 The percentage of various immune cell populations in the testis of SP-D
-/-
 and WT mice 287 
was evaluated by flow cytometry. Briefly, the testis tissues from 8 week old SP-D
-/-
 (n = 10) and 288 
WT mice (n = 10) were dissected, washed three times in cold PBS and the tunica albuginea was 289 
removed. The seminiferous tubules were dispersed but not fragmented in 0.5 mg/ ml collagenase 290 
type I solution (Sigma) for 15 min at room temperature. The enzymatic digest was passed though 291 
70 µm mesh (BD, USA) to separate interstitial cells and seminiferous tubules. The interstitial 292 
cell suspension containing the immune cells of the testis was washed twice with cold FACS 293 
buffer [PBS with 1 % BSA, (GeNei
TM
)]. Next, the cells were fixed in 4 % (w/v) formalin 294 
(Qualigens) and blocked with 3 % BSA (GeNei
TM
) for 30 min.  The cell suspension was 295 
incubated with the fluorochome tagged primary antibodies against immune cell specific markers, 296 
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such as rat monoclonal anti-mouse F4/80-phycoerythin (PE) (1:30 in 100 μl for 10
6
 cells, 297 
ab105156, Abcam), Armenian Hamster monoclonal to CD11c-PE (1:50 in 100 μl for 10
6
 cells, 298 
ab86901, Abcam) and mouse T lymphocyte subset antibody cocktail: PE-Cy
TM
7 CD3e, PE CD4, 299 
APC CD8a (20 μl in 100 μl for 10
6
 cells, 558431, BD Pharmingen)  for 40 min at 4°C. After 300 
final wash in FACS buffer, the cells were analysed using BD FACS AriaTM SORP flow 301 
cytometer (BD Biosciences, San Jose, CA, USA). Matched isotype controls were used as 302 
negative controls for each experiment.  303 
 304 
Statistical analysis 305 
 The data were analysed using GraphPad Prism Version 6 software (Graph Pad Inc., San 306 
Diego, CA, USA). Non-parametric Mann-Whitney test was used for a comparison between the 307 
two groups and Kruskal-Wallis test followed by post hoc test (Dunn’s multiple comparison tests) 308 















Normal morphology of testis and epididymis in SP-D
-/-
 mice 322 
In order to understand the importance of SP-D in male fertility, we first sought to 323 
compare the morphology of the testis and epididymis between SP-D
-/-
 and WT mice. The weight 324 
of testis and epididymis in 8 week old SP-D
-/-
 mice (64 ± 3.26 and 26.05 ± 1.79 mg, respectively) 325 
was significantly low as compared to the age matched WT mice (84 ± 5.99 and 34.58 ± 2.61 mg, 326 
respectively), (Fig 1A and B). Importantly, a decreased length of the epididymis with less 327 
convoluted cauda was also observed in SP-D
-/-
 mice (Fig 1A). However, despite these 328 
phenotypical differences, the histological staining of testis and epididymis from SP-D
-/-
 mice 329 
revealed a normal structure with no significant difference relative to the WT mice (Fig S2). 330 
Apparently, we did not find any  significant difference in the body weights of SP-D
-/-
 (26.65 ± 331 
1.78 gm) and WT mice (27.90 ± 2.43 gm). Interestingly, measurement of the serum and intra-332 
testicular levels of steroid hormones revealed significantly lower serum levels of testosterone 333 
(2500 ± 500 vs 4200 ± 840 pg/ ml) in SP-D
-/-  
mice with no significant difference in the serum 334 
levels of estradiol (55.70 ± 5.50 vs 72.64 ± 7.20 pg/ ml respectively) than WT mice (Fig 1C). 335 
Moreover we did not find any substantial difference in the intra-testicular levels of these 336 
hormones between SP-D
-/-
 and WT mice (100 ± 20 vs 80 ± 16 pg testosterone/ mg of testis and 337 
0.608 ± 0.12 vs 0.59 ± 0.11 pg of estradiol/ mg of testis) (Fig 1D).  338 
 339 
Motility of caudal sperm  340 
 The motility parameters of the sperm preparations from cauda epididymis of SP-D
-/-
 and 341 
WT mice were evaluated by CASA. No significant difference in the total motility (79.7 ± 11.7 vs 342 
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89 ± 6.4 % respectively) (Fig 2A) and progressive motility (30.3 ± 4.7 vs 28 ± 2.5 % 343 
respectively) (Fig 2B) was observed in the sperm suspensions from SP-D
-/-
 and WT mice. An 344 
assessment of the mean values of various motility parameters revealed decreased vigour 345 
parameters [curvilinear velocity (VCL), lateral amplitude (ALH) and beat frequency (BCF)] and 346 
increased progression parameters [progressive velocity (VSL), path velocity (VAP), straightness 347 
(STR) and linearity (LIN)] in the sperm preparation from SP-D
-/-
 mice compared to WT mice, 348 
although only mean BCF and LIN values showed a statistically significant difference (Table 2).  349 
 We also determined the effect of LPS induced inflammation on the sperm count and 350 
motility following an i.p. administration of a high dose of LPS for 24 h. Although, the caudal 351 




± 0.2 x 10
6 
cells/ cauda) was lower than the WT mice (3.94 ± 352 
2.6 x 10
6 
cells/ cauda) in control groups, the levels did not reach a statistical significance (Fig 353 
2C). LPS treatment did not lead to any significant alteration in the sperm count in WT mice (3.1 354 
± 1.5 x 10
6
 cells/ cauda) compared to its levels in control WT mice. However, it resulted in a ~ 4 355 
fold decrease in the sperm count (4.8 ± 1.6 x 10
5
 cells/ cauda) in the LPS treated SP-D
-/- 
mice 356 
compared to the untreated control SP-D
-/-
 mice (Fig 2C). While LPS challenge reduced the 357 
percentage of total and progressive sperm motility in SP-D
-/-
 as well as WT mice, the difference 358 
in the values was not statistically significant (Fig 2A and B). Although LPS administration 359 
reduced the percentage of rapidly motile sperm and increased the percentage of static sperm in 360 
both SP-D
-/- 
and WT mice, the differences in the values for velocity distribution between the two 361 
genotypes were not statistically significant (Fig 2D). 362 
 363 
In vitro capacitation 364 
17 
 
To further explore the functional differences in sperm derived from SP-D
-/- 
and WT mice, 365 
sperm preparations were incubated under in vitro capacitating conditions at different time points. 366 
Immunoblotting analysis was performed to assess the protein tyrosine phosphorylation, which is 367 
a characteristic of capacitated sperm. Our results revealed a time dependent increase in the 368 
degree of protein tyrosine phosphorylation in JAK-2 pathway in sperm suspesion from both SP-369 
D
-/-
 and WT genotype (Fig 3A). Interestingly, the degree of protein tyrosine phosphorylation was 370 
considerably low in the sperm preparation from SP-D
-/-
 mice compared to the WT (Fig 3B), 371 




 male mice 374 
To determine the effect of SP-D deficiency on fecundity, we individually co-habited 375 
sexually mature SP-D
-/-
 and WT males with WT female mice for 2 months. The mating ability of 376 
SP-D
-/-
 male mice was comparable to that of WT mice, based on the pregnancy rate in female 377 
mice. Mating studies revealed no significant difference between the SP-D
-/- 
and WT mice in the 378 
parameters indicative of fertility including the litter size and litter weight (Table 3). 379 
 380 
Increased levels of immunoregulatory molecules in the testis  381 
To evaluate the importance of SP-D in testicular immune privilege, we determined the 382 
levels of various immunoregulatory molecules in the testis of SP-D
-/- 
mice compared to the WT 383 
mice under physiological conditions. The analysis of mRNA expression revealed significantly 384 
increased levels of immunosuppressive molecules, such as serpina3 (~ 2.6 fold), TGF-β1 (~ 1.9 385 
fold) and IL-10 (~ 2 fold) in the testis of SP-D
-/- 
mice than WT (Fig 4A and B). Interestingly, the 386 
testis of SP-D
-/- 
mice also showed higher levels of pro-inflammatory cytokines, such as TNF-α (~ 387 
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1.4 fold) and IL-1α (~ 1.3 fold), (Fig 4C). Significantly reduced levels of the immunosuppressive 388 
molecules, such as IDO (~ 1.6 fold), Activin-B (~ 2 fold), and Inhibin-B (~ 2.7 fold), and of pro-389 
inflammatory cytokines, such as KC (~ 2 fold) and IL-6 (~ 2 fold) in SP-D
-/-
 mice compared to 390 
the WT were observed (Fig 4A, B and C). There was no significant difference in the levels of 391 
MMP-2, MMP-9 and MMP-12. Although SP-A levels did not change, a ~ 2.3 fold higher level 392 
of MBL-A transcripts was observed in the testis of SP-D
-/-
 mice (Fig 4D). Next, we assessed the 393 
protein levels of these molecules in the testis of mice from both the genotypes by multiplex 394 
cytokine assay and immunoblotting. Consistent with our transcript data, the testis of SP-D
-/- 
mice 395 
exhibited significantly higher protein levels of Serpina3 (~ 2.2 fold), IL-12p40 (~ 7.5 fold), TGF-396 
β1 (~ 2 fold), IL-10 (~ 1.6 fold) and TNF-α (~ 2 fold) than WT mice (Fig 4E, F, G and H). Thus, 397 
a significant alteration of testicular immune milieu in SP-D
-/-
 mice was evident, which suggests a 398 
role for SP-D in the maintenance of immune homeostasis within the testis.  399 
 400 
Reduced levels of immune cell activation markers  401 
To further characterize the immune status of the testis of SP-D
-/-
 mice, we enumerated the 402 
percentage of immune cells in testicular interstitial spaces. Flow cytometric analysis showed no 403 
significant difference (Fig 5A) in the percentage of testicular immune cells between SP-D
-/- 
and 404 
WT mice; these included F4/80
+ 
macrophages (5.7 ± 1.3 % vs 4.4 ± 1.8 %) (Fig S3 A), CD11c
+
 405 
dendritic cells (5.0 ± 0.7 % vs 7.1 ± 2.2 %) (Fig S3 B), CD4
+
 T lymphocytes (0.2 ± 0.08 % vs 406 
0.2 ± 0.1 %) (Fig S3 C), and CD8
+
 T lymphocytes (0.3 ± 0.1 % vs 0.3 ± 0.09 %) (Fig S3 D). 407 
Interestingly, comparison of the testicular levels of immune cell activation markers revealed 408 
significantly lower levels (~ 2 fold) of CD86 and IL-2 (Fig 5B, D and E) in the SP-D
-/-
 mice, thus 409 
indicating a reduced activation status of immune cells in the testis of SP-D
-/- 
mice. We also 410 
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evaluated the testicular mRNA expression of ITGAX and MRC1, markers for M1 and M2 411 
macrophages, respectively and observed a significantly decreased (~ 3.85 fold and ~ 2.4 fold 412 
respectively) transcript levels of both the markers in the testis of SP-D
-/-
 mice compared to WT 413 
mice (Fig 5C). Although the ratio of M2/M1 macrophages in both WT (~ 1.39) and SP-D
-/-
 mice 414 
(~ 2.09) showed a predominance of M2 marker, the proportion of M2 marker was higher in the 415 
SP-D
-/-
 than WT mice, suggesting an immuno-regulatory phenotype in the knockout mice testis. 416 
 417 
Blunted inflammatory response to LPS in the testis  418 
To analyse the relevance of SP-D in inflamed testis, we used LPS induced systemic 419 
inflammation model by intra-peritoneal administration of low and high dose of LPS. LPS 420 
administration to the WT mice resulted in an up-regulation of pro-inflammatory cytokines in the 421 
testis, while the SP-D
-/-
 mice showed a blunted inflammatory response to LPS challenge. 422 
Though, LPS treatment up-regulated the testicular levels of MCP-1 and RANTES in SP-D
-/-
 423 
mice similar to the WT mice (Fig 6A and B), LPS challenged SP-D
-/-
 mice showed blunted 424 
immune response for TNF-α, IL-10, IL-12p40, MIP-1α, G-CSF and IL-6 compared to their 425 
levels in WT mice (Fig 6). 426 
We also analysed the levels of testosterone and estradiol in the testis of LPS treated mice. 427 
There was no significant difference in the basal testicular levels of both hormones in SP-D
-/-
 and 428 
WT mice. Moreover, LPS treatment did not significantly alter the levels of testosterone at both 429 
low and high dose of LPS at 6 h and 24 h time points in murine testis from both the genotypes 430 
(Fig 7A). Interestingly, a significant increase in the intra-testicular level of estradiol was 431 
observed in both SP-D
-/-
 and WT mice following LPS challenge (Fig 7B). This increase was 432 
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significantly higher in SP-D
-/-
 mice in the high dose of LPS treated group at both 6 and 24 h and 433 
in the low dose group at 6 h time point. 434 
 435 
Protective effect of  exogenous  rhSP-D on LPS induced testicular inflammation and sperm 436 
motility 437 
 To further confirm the role of SP-D in the regulation of LPS induced immune response in 438 
the testis, we treated LPS challenged WT mice with exogenous rhSP-D and examined the 439 
testicular histology, cytokine response, and sperm motility.  440 
 The histological analysis of testis from the LPS challenged mice showed vacuolization 441 
and an increase in the intercellular gaps in seminiferous epithelium due to disruption of cell-to-442 
cell contact (Fig S4). Although the testis from rhSP-D treated and LPS challenged mice also 443 
showed  the presence of intercellular gaps and vacuoles in seminiferous epithelium, the number 444 
of tubules showing such features were fewer, compared to untreated group (Fig S4).  445 
As evident from the intra-testicular transcript levels of cytokines, the LPS treatment 446 
resulted in a pro-inflammatory response involving a significant down-regulation of TGF- β1 447 
levels (~ 6 fold) and a concomitant up-regulation of TNF- α (~ 15.22 fold) compared to the saline 448 
control group (Fig S5). The rhSP-D treatment of the  LPS challenged mice significantly 449 
increased the levels of all thee cytokines: TGF-β1 (~ 2.79 fold), IL-10 (~ 27.66 fold) and TNF- α 450 
(~ 73.26 fold) compared to the saline control group (Fig S5).  We found a preponderance of an 451 
anti-inflammatory milieu in the rhSP-D treated mice (viz., ~ 15.67 fold up-regulation of TGF-β1, 452 
~ 21.40 fold up-regulation of IL-10 and ~ 4.8 fold up-regulation of TNF- α), compared to the 453 
untreated group (Fig 8A). It appears that  SP-D could be an important molecule in the regulation 454 
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of inflammatory responses in the testis, thus impacting upon local immune homeostasis, and 455 
consequently, the male fertility.  456 
Further analysis of the sperm motility of these mice by CASA revealed that LPS 457 
challenge led to a significant decrease in the percentage of total sperm motility (57 ± 8.5 %) and 458 
an increase in the  percentage of static sperm (25 ± 10.6 %) compared to the saline control group 459 
(91.67 ± 2.5 %) and (2.6 ± 1.5 %) respectively (Fig 8B and C). Remarkably, treatment with 460 
rhSP-D was effective in restoring the total motility (90 ± 5.2 %) of sperm and in reducing the 461 
percentage of static sperm (1.67 ± 0.6 %) that was hampered by LPS challenge (Fig 8B and C) 462 


















The present study demonstrates an integral role of SP-D in immune regulation of the 479 
testis and sperm functions. Our findings reveal that systemic absence of SP-D altered the 480 
immune milieu of the testis, leading to a reduced immune cell activation and subdued 481 
inflammatory response to LPS challenge. Importantly exogenous supplementation of rhSP-D  482 
negated the effect of LPS induced inflammation in the testis and on sperm motility in WT mice. 483 
Protein tyrosine phosphorylation was significantly reduced in capacitated sperm derived from 484 
SP-D
-/-
 mice relative to WT mice, suggesting  that SP-D may contribute to sperm capacitation 485 
process.  486 
Increased infiltration of large, foamy macrophages, activated T lymphocytes
 
and elevated 487 
proinflammatory cytokines
 




. In contrast, 488 
in testis, an immune privileged organ unlike lungs, we observed significantly increased levels of 489 
immunoregulatory molecules in SP-D
-/- 
mice indicating a dominance of immune-suppressive 490 
milieu in the testis of these mice. This inference was further supported by the reduced levels of 491 




suggesting a 492 
reduced activation status and function of testicular immune cells. In addition, we found a 493 
predominance of M2 macrophage marker (MRC1) associated with macrophages involved in 494 
immune suppression
27
. The M1 macrophages secrete inflammatory cytokines such as IFN-γ and 495 
TNF-α and produce nitric oxide (NO). The M2 macrophages are regulatory macrophages with 496 
high phagocytosis potential and produce IL-10. They clear apoptotic cells, can mitigate 497 




Collectively these data suggest the 498 
predominance of an overall immunosuppressive milieu in the testis of SP-D
-/- 
mice.  499 
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A complex interplay between multiple immunological factors, is indispensible to protect 500 
auto-antigenic spermatozoa in the testis, which is a pre-requisite for normal fertility
3
. Therefore 501 
an increase in the other immune suppressive molecules and modulation of the immune cell 502 
functions could be a compensatory mechanism to restore the dysregulation caused by an absence 503 
of SP-D with an aim to preserve fertility. 504 
Levels of SP-D are known to increase at the site of infection and inflammation
11
. 505 
Recently, we demonstrated an LPS induced increase in the levels of SP-D in murine testis
8
. SP-D 506 
inhibits LPS mediated effects via direct interaction with LPS as well as with LPS receptors 507 
TLR4/MD2, TLR2 and CD14
19, 20, 21
. In view of an overall increase in testicular 508 
immunosuppressive milieu, we hypothesized that the testis of SP-D
-/-
 mice would exhibit 509 
alterations in inflammatory response to LPS challenge. As expected, we found a reduced severity 510 
of inflammatory reaction in the testis following LPS challenge, reaffirming immunosuppressive 511 
microenvironment within the testis of SP-D knock-out mice.  512 
Previously, a decline in serum and intra-testicular levels of testosterone at 6 and 18 h 513 
after LPS administration has been reported in rats
28
. However, in our study, we did not find any 514 
significant difference in the intra-testicular levels of testosterone post LPS challenge. Notably, 515 
we found a significant increase in the levels of estradiol after LPS treatment. Earlier studies have 516 
reported estradiol mediated suppression of the LPS induced inflammatory responses at various 517 
sites including H9c2 cardiomyoblast cells, murine lung and bone marrow derived macrophages
29, 518 
30, 31
. Thus an increase in the testicular levels of estradiol upon LPS challenge may be a specific 519 
feedback response to regulate  inflammation in the absence of SP-D. It would be interesting to 520 
examine the testicular aromatase activity in this regard. 521 
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Another strategy to unravel the role of SP-D in testicular inflammation was exogenous 522 
supplementation of rhSP-D in the WT mice challenged with LPS. Consistent with the 523 
involvement of SP-D in controlling inflammation, we observed a protective effect of rhSP-D 524 
against LPS induced inflammatory response in the testis and sperm motility, thus highlighting 525 
the beneficial properties of SP-D in inflammation associated male infertility.  Though 526 
endogenous absence of SP-D led to a pro-inflammatory response in the lungs
21
, and murine 527 
uterus
23
, a predominance of immune-suppressive milieu was observed in the testis, a unique 528 
phenomenon plausibly associated with the immune-privileged nature of this organ. 529 
Compensatory mechanisms could have led to the alteration in the levels of other 530 
immunoregulatory molecules to perform the role that was played by SP-D. Though observations 531 
from the two strategies seem to be contradictory, they converge to suggest that SP-D regulates 532 
the testicular immune milieu. On similar lines, Perez et al., 2015, reported that exogenous 533 
administration of recombinant Gal-1 (galectin-1, a β-galactoside binding immunoregulatory 534 
protein) attenuates the severity of experimental autoimmune orchitis (EAO), whereas, Gal-1 535 
deficient mice showed significant reduction in the incidence and severity of EAO
32
. 536 
               Importantly, male mice with the targeted deletion of SP-D gene exhibited a decrease in 537 
certain components of masculine parameters. They had lower serum levels of testosterone and 538 
decreased weight of testes and epididymis. Though under normal physiological conditions the 539 
caudal sperm count of SP-D
-/-
 mice was lower than WT mice, levels did not reach statistical 540 
significance. In spite of exhibiting a blunted response to LPS induced inflammation in testis, a 541 
significant reduction of caudal sperm count in LPS challenged SP-D
-/- 
mice was surprising. In 542 
this regard, future studies involving DNA flow cytometry of testicular spermatogenic cells using 543 
propidium iodide staining will ascertain if the reduced sperm count is due to a defect at testicular 544 
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level. It will be relevant to evaluate the incidence of LPS induced germ cell apoptosis in SP-D
-/-
 545 




 mice 546 
displayed a decreased length of the epididymis with less convoluted cauda. Changes in the 547 
convoluted nature of cauda can directly affect the quantity of spermatozoa retained in the 548 
epididymis, and could be a reason for the reduced caudal sperm count in SP-D
-/- 
mice. 549 
Furthermore, there is a possibility that SP-D may have cauda specific roles.  550 
We have previously reported the localization of SP-D on murine spermatozoa
8
. 551 
Therefore, to understand the putative role of SP-D in sperm functions, we first compared the 552 
sperm motility parameters of SP-D
-/-
 mice with the WT. No difference in the percentage of total 553 
and progressive sperm motility was observed in sperm suspension from both the genotypes. In 554 
addition, we evaluated the capacitation induced protein tyrosine phosphorylation in sperm 555 
suspensions from SP-D
-/- 
and WT mice. Many biochemical and physiological changes have been 556 
described for sperm incubated under capacitating conditions. These include an efflux of plasma 557 
membrane cholesterol, increased adenylate cyclase activity, increased cAMP levels, 558 
hyperpolarization of membrane potential and increased serine/threonine and tyrosine 559 
phosphorylation of some proteins
33, 34
. Thus, we evaluated the tyrosine phosphorylation in JAK2 560 
pathway as a measure of capacitation for sperm suspensions incubated under in vitro capacitating 561 
conditions
35
. The observation that SP-D
-/-
 mice exhibit considerably reduced tyrosine 562 
phosphorylation in capacitated sperm appears to implicate SP-D in the sperm capacitation 563 
process. Cytokines are known to influence sperm cell capacitation process in a positive or 564 
negative manner. Importantly, interferon – α (IFN- α), interferon- γ (IFN- γ) and TNF- α 565 
negatively affect sperm motility, while IL-6 is known to enhance sperm capacitation and 566 
acrosome reaction in vitro
36, 37





, SP-D could be an important molecule involved in regulating sperm capacitation 568 
process. 569 
 Majority of the proteins that undergo phosphorylation at tyrosine residues during 570 
capacitation are localized on the sperm flagellum
38
. We have previously shown the localization 571 
of SP-D throughout the length of the flagellum of murine spermatozoa
8
. Our results of sperm 572 
motility analysis showed decreased vigour parameters (VCL, ALH and BCF) and increased 573 
progression parameters (VSL, VAP, STR and LIN) in SP-D
-/-
 mice. Altogether, these findings 574 
highlight the involvement of SP-D in sperm capacitation, a process characterized by vigorous 575 
sperm motility. Thus, understanding the involvement of SP-D in sperm acrosome reaction as 576 
well as sperm- egg interaction via in vitro fertilization assay would be crucial in defining the 577 
specific role of SP-D in the fertilization process.  578 
Despite relatively low caudal sperm count and decreased sperm vigour parameters in SP-579 
D
-/-
 mice, mating studies did not reveal any defect in the fecundity of SP-D
-/-
 mice. This is not 580 
surprising since the sperm count should be reduced to 10% or less in order to influence fertility
39
. 581 
Previously knock-out male mice with targeted deletion of genes having important roles in the 582 
testis such as IL-12p40
40
, ADP-Ribosylation Factor-Like 4 protein (Arl4)
41
, follicle-stimulating 583 
hormone β (FSH β)42 and activin II receptor A (ActRcIIA)43, exhibited normal fertility even with 584 
the reduced sperm count or testicular weight. It is worth noting that the female reproductive tract 585 
is equipped with an efficient mechanism to select a few, but high quality fertilizing sperm that 586 
ultimately reach the ampulla, thus compensating for the reproductive deficiencies males may 587 
have. The defects in sperm functions could thus be masked by such proficient selection system. 588 
These sperm defects may possibly be evident when knock-out mice are mated under more 589 
challenging conditions such as by unilateral vasectomy to reduce the number of ejaculated 590 
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sperm, or by mating with super-ovulated females with high number of eggs in ampulla
44, 45
.  591 
Recently Cysteine-rich secretory protein 2 (Crisp2) and galectin-1 (Gal-1) gene knock-out mice 592 
were described to show defects in fertilization in vivo, only under such restricted mating 593 
conditions
44, 45
.   594 
A detailed understanding of the putative roles of SP-D in male fertility will require 595 
additional studies, ideally involving the use of testis-specific knock-down model, restricted 596 
mating trials, and in vitro fertilization assays. Nevertheless, the current study provides first 597 
evidence for the involvement of SP-D in regulating testicular immune privilege and male 598 
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Figure Legends 790 
Figure 1: Weight of the testis and epididymis and hormone levels  791 
Size (A) and weight (B) of the testis and epididymis of SP-D
-/-
 and WT mice. Both the size and 792 
weight of testis and epididymis are significantly smaller, with less convoluted cauda in SP-D
-/-
 793 
mice. Bar graphs representing (C) Serum and (D) Intra-testicular levels of testosterone and 794 
estradiol in WT and SP-D
-/- 
mice assayed using specific ELISA kits. Significantly reduced serum 795 
levels of testosterone while no significant difference in the intra-testicular levels of both 796 
hormones was found in SP-D
-/- 
mice. Data represents the mean of five independent 797 
determinations; error bar represents the S.D. *, p < 0.05.  798 
 799 
Figure 2: Sperm motility parameters in the LPS treated SP-D
-/-
 and WT mice. Assessment 800 
of motility by CASA revealed no significant difference in the (A) total and (B) progressive 801 
motility between the sperm suspensions from SP-D
-/-
 and WT mice in both control and LPS 802 
treated groups. (C) Significantly reduced sperm count in SP-D
-/-
 mice upon LPS challenge. (D) 803 
Comparison of velocity distribution between sperm suspension from SP-D
-/-
 and WT mice in 804 
control and LPS treated groups revealed no significant differences. Data represents the mean of 805 
five independent experiments; error bar represents the S.D. *, p < 0.05.  806 
 807 
Figure 3: Reduced degree of protein tyrosine phosphorylation in capacitated sperm from 808 
SP-D
-/-
 mice. (A) Sperm suspensions from SP-D
-/-
 and WT mice were incubated in vitro in 809 
capacitation media for 0, 15, 60 and 90 min respectively and protein tyrosine phosphorylation 810 
was assessed using anti-mouse pJAK-2 antibody by western blotting. (B) Densitometric analysis 811 
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showing significantly reduced degree of protein tyrosine phosphorylation in SP-D
-/-
 mice relative 812 
to WT mice. α- tubulin was used as an internal loading control. The data are representative of 5 813 
independent experiments; error bar represents the S.D. *, p < 0.05, **, p < 0.001. 814 
 815 
Figure 4: Altered immune milieu in the testis of SP-D
-/-
 mice. 816 
(A- H) Levels of cytokines and immunosuppressive molecules were assayed in the testis of SP-817 
D
-/-
 and WT mice using real time RT-PCR, western blot and multiplex cytokine assay. Results 818 
revealed significantly different immune milieu in the testis of SP-D
-/- 
mice with a pre-dominance 819 
of immunosuppressive molecules. 18s and β- actin were used as internal loading controls for 820 
transcript and immunoblot analysis, respectively. Data represents the mean of five independent 821 
experiments, error bar represents the S.D. *, p < 0.05, **p < 0.001.  822 
 823 
Figure 5: Reduced activation status of immune cells in the testis of SP-D
-/-
 mice.  824 
(A) Bar graph summarizing the percentage of immune cells in the testis of SP-D
-/-
 and WT mice. 825 
Data represents the mean of ten independent experiments, error bar represents the S.D. No 826 
significant difference in the number of intra-testicular immune cells was observed between the 827 
two genotypes. Real time RT- PCR (B), and western blot analysis (D) and (E) was carried out to 828 
evaluate the intra-testicular levels of immune cell activation markers in SP-D
-/-
 and WT mice. 829 
The testis of SP-D
-/-
 mice showed significantly reduced levels of CD86 and IL-2. (C) Transcript 830 
level analysis of M1 and M2 macrophage marker viz., ITGAX and MRC1 respectively revealed 831 
significantly reduced levels of both markers in the testis from SP-D
-/-
 than WT mice. 18s and β- 832 
actin were used as internal loading controls for transcript and western blot analysis respectively. 833 
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Data represents the mean of five independent experiments; error bar represents the S.D. **, p < 834 
0.001.  835 
 836 
Figure 6: Blunted inflammatory response to LPS challenge in the testis of SP-D
-/-
 mice. (A - 837 
H) Multiplex cytokine analysis of whole testicular protein lysates was carried out from SP-D
-/-
 838 
and WT mice injected with high (5 mg/ kg) or low dose (0.1 mg/ kg) of LPS, or saline for 6 h 839 
and 24 h. The testis of SP-D
-/-
 mice showed a blunted response to LPS induced up-regulation of 840 
pro-inflammatory cytokines. (H6- high dose LPS treated for 6 h, H24- high dose LPS treated for 841 
24 h, L6- low dose LPS treated for 6 h and L24- low dose LPS treated for 24 h). Bar graphs 842 
represent the mean of 6 values for each time point and dose of LPS; error bar represents S.D. *, p 843 
< 0.05, **, p < 0.001.  844 
 845 
Figure 7: Significant increase in the levels of estradiol upon LPS challenge. 846 
Levels of (A) Testosterone and (B) Estradiol were assessed in the testis of SP-D
-/-
 and WT mice 847 
6 h and 24 h following LPS challenge by hormone specific ELISA kits. No significant 848 
differences in the levels of testosterone (A) were observed in control and treatment group 849 
between the two genotypes. However, LPS treatment resulted in a significant increase in the 850 
levels of estradiol (B) in the testis of both WT and SP-D
-/-
 mice. This increase was significantly 851 
higher in SP-D
-/-
 mice than WT mice. Data represents the mean of five independent experiments; 852 
error bar represents the S.D. *, p < 0.05.  853 
 854 
Figure 8: Protective effect of exogenous rhSP-D on LPS induced inflammation in testis and 855 
sperm motility.  856 
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High dose LPS challenged WT mice were treated with exogenous rhSP-D for 24 h and the levels 857 
of intra-testicular cytokines were assayed by real time RT-PCR, while the sperm motility was 858 
assessed by CASA. (A) Comparing the levels of cytokines in rhSP-D treated LPS challenged 859 
mice to that of LPS alone challenged mice showed a predominance of anti-inflammatory milieu 860 
in rhSP-D treated group. (B) Significant decrease in the percentage of total sperm motility and 861 
(C) increased percentage of static sperm in LPS challenged mice compared to the saline control 862 
group. Treatment with rhSP-D restored the total motility of sperm and reduced the percentage of 863 
static sperm that was hampered by LPS challenge to control levels. Data are representative of 5 864 
independent experiments; error bar represents the S.D. *, p < 0.05. 865 
 866 
Figure S1: Genotyping of SP-D
-/-
 mice.  867 
Representative agarose gel image showing PCR products amplified using SP-D (exon 2) and 868 
Neo gene specific primer pairs. Genomic DNA from SP-D
-/- 
and WT mice was subjected to PCR 869 
and (A) SP-D gene specific amplicon (204 bp) was obtained only in WT mice while (B) Neo 870 
gene specific PCR amplification product (249 bp) was seen in the DNA sample from SP-D
-/- 871 
mice. This confirmed the presence of normal and recombinant SP-D gene in WT and SP-D
-/- 872 
mice respectively. 873 
 874 
Figure S2: Morphology of the testis and epididymis. 875 
Histology of the testis (a, b), cauda epididymis (c, d) and initial segment of epididymis (e, f) 876 
from 8 week old WT and SP-D
-/-
 mice respectively showing normal architecture in SP-D
-/- 
mice 877 
compared to the WT, (scale bar = 100 μm). Insets show higher magnification images (scale bar = 878 




Figure S3: Percentage of intra-testicular immune cells  881 





 DC cells, (C) CD4
+
 lymphocytes and (D) CD8
+
 lymphocytes in the 883 
interstitial spaces of the testis from SP-D
-/-
 and WT mice. Black line represents the fluorescence 884 
for stained population, while gray line represents the isotype control antibody fluorescence. Data 885 
are representative of mean ± S.D. of ten independent experiments.  886 
 887 
Figure S4: Protective effect of exogenous rhSP-D supplementation on testicular 888 
morphology in LPS challenged WT mice. 889 
The histological analysis of testis from (a) control, (b) LPS challenged and (c) LPS challenged 890 
group treated with exogenous rhSP-D. (a) Testicular section from saline control group showing 891 
normal architecture. (b) Morphology of the testis from LPS challenged group revealed 892 
vacuolization (yellow arrow-heads) and intercellular gaps (black arrow) in seminiferous 893 
epithelium due to disruption of cell-cell contact. (c) The testis from rhSP-D treated LPS 894 
challenged mice shows protective effect of rhSP-D on inflammation induced alterations in 895 
morphological features of the testis. (Scale bar = 100 μm). Insets represent higher magnification 896 
images (scale bar = 20 μm). Data are representative of five independent determinations. 897 
 898 
Figure S5: Effect of exogenous rhSP-D treatment on transcript levels of cytokines in LPS 899 
induced inflammation in testis. 900 
Analysis of transcript levels of cytokines viz., (A) TGF-β1, (B) IL-10 and (C) TNF-α revealed 901 
that the LPS treatment resulted in a pro-inflammatory response by significant down-regulation of 902 
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TGF- β1 levels with significant increase in the levels of TNF- α compared to the saline control 903 
group. Treatment with exogenous rhSP-D in LPS challenged mice significantly increased the 904 
levels of all three cytokines compared to the control and LPS challenged group with a 905 
predominance of anti-inflammatory cytokines. Data are representative of 5 independent 906 
























(5’ → 3’) 
Reverse Primer 
(5’ → 3’) 
Amplicon 
Size (bp) 
SP-D GCAGGACATGCTGCCCTTTCT ACCCTTCTCACCCCGTGGACC 204 
Neo TTCGGCTATGACTGGGCACAACAG TACTTTCTCGGCAGGAGCAAGGTG 249 
CD274 TGCTGCCCTTCAGATCACAG TTCTGGATAACCCTCGGCCT   148 
Serpina3 AACATGCCAGGCAAGCGGCA AGCAGGGCAGATCCCAGCCAT 150 
IDO GCAGGCCAGAGCAGCATCTTCC CGGTGGGCTGGAGGCATGTA 122 
FasL GGTTCTGGTGGCTCTGGTTGGA GGGTGTACTGGGGTTGGCTATTTGC 146 
TGF-β1 GCGTGCTAATGGTGGACCGCA GCACGGGACAGCAATGGGGG 130 
IL-10 GCACCCACTTCCCAGTCGGC GGCTTGGCAACCCAAGTAACCCT 158 
Activin-A GGCTCAGGACATCACCCAGGTCC CTCAAAGAGGAGGGCTGGGGCT 140 
Activin-B CCATCACAGAGGCCATCCAG CAGTCGTTCCAGCCGATGAG 271 
Inhibin-A TTGCCCAGGAGGCTGAGGAAG GGGTGGGTCAGCAGAGGGAAA 271 
Inhibin-B GGGTCCGCCTGTACTTCTTC CCTGGATGGCCTCTGTGATG 243 
KC GGTGAGGACATGTGTGGGAG CGAGACCAGGAGAAACAGGG 185 
TNF-α GGGCCACCACGCTCTTCTGTCT GATCCATGCCGTTGGCCAGGAG 237 
IL-1α GCGCTCAAGGAGAAGACCAGCC GTGCCAGGTGCACCCGACTTT 186 
MIF ATCGCCTGCACATCAGCCCG TCTCCCGGCTGGAAGGTGGG 193 
IL-6 AGACAAAGCCAGAGTCCTTCAGAGA GCCACTCCTTCTGTGACTCCAGC 146 
MMP-2 CAGGGCACCTCCTACAACAG CCACTTCCGGTCATCATCGT  270 
MMP-9 TTTGAGGGCCGCTCCTACTC GATGTGGTCGCACACCAGAG 251 
MMP-12 GCTGTCACAACAGTGGGAGA GCAGAGAAGCCCAGGGAATA 257 
SP-A ACCTGGATGAGGAGCTTCAGACTC TGCTTGCGATGGCCTCGTTCT 225 
43 
 
MBL-A ACCAGGTCAAGGGCTCAGGGG TGCCAGCTTCTCCTCAATGGCTC 182 
CD40L TTGCAGCACACGTTGTAAGC TGAATGGGCGTTGACTCGAA 204 
MHC II AGACACCCAGGGCCTTTATG AAAGCAAGTTGGGGGTCACT 154 
CD86 ACGGAAGCACCCACGATGGA CCTGTCAAAGCTCGTGCGGC 285 
IL-2 TCCTTGTCAACAGCGCACCC CATGCCGCAGAGGTCCAAGT 261 
MRC1 TTTGCCTTTCCCAGTCTCCC CCTCGCGTCCAATAGCTGAA 122 
ITGAX CTCACCCAGCCAGAGGATTT CAGTGGCATCACTCAGTGTCT 263 
18s GGAGAGGGAGCCTGAGAAAC CCTCCAATGGATCCTCGTTA 175 


















Table 2 Sperm motility parameters  942 
 943 
Various motility parameters of caudal sperm suspension from saline control and LPS treated WT 944 
and SP-D
-/-
 mice were analyzed by CASA. VAP (Average path velocity), VSL (straight line 945 
velocity), VCL (curvilinear velocity), ALH (lateral amplitude), BCF (beat frequency), STR 946 
(straightness), LIN (linearity). Data are expressed as mean ± SD, n = 5 per group, *p < 0.05.   947 
 948 
Table 3 Fertility of SP-D
-/-





(No. of pups) 
Litter weight 
(gm) 
Time to delivery 
(days) 
WT 100.0 8.4 ± 0.5 13.0 ± 1.0 26.4 ± 3.9 
SP-D
-/-





























































































































Wild type (WT) or knockout (SP-D
-/-
) males were caged with WT females for 2 months. The 950 
percentage of pregnant females, litter size, litter weight and the time to delivery from the day 951 
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